Ryght, a leader in real-time generative AI for clinical research, announced that the prestigious Winship Cancer Institute of Emory University has joined its global Ryght Research Network, which creates an AI-powered digital twin of every research site worldwide. Esteemed institutions like Winship use Ryght’s platform to transform clinical trial processes and streamline workflows.
As Georgia’s only NCI-designated comprehensive cancer center, Winship is renowned for its patient-focused care, cutting-edge research, and mission to improve outcomes for all cancer patients — a vision aligned with Ryght’s. By joining the Ryght Research Network, Winship brings innovative AI solutions to enhance the scope and efficiency of its clinical research and trial operations.
“We are thrilled to join the Ryght Research Network and bring advanced AI solutions to our patients and staff,” said Suresh Ramalingam, MD, Executive Director of Winship. “Our dedication to excellence in cancer research aligns perfectly with Ryght’s goals as we streamline processes, accelerate access to therapies, and deliver the right studies to patients faster.”
The Ryght Research Network uses generative AI to analyze site-specific and industry-wide data in real time, helping sponsors and CROs identify optimal sites while enabling sites to make data-driven decisions. By automating tasks like site selection, feasibility assessment, budgeting, and patient referrals, the network replaces traditional workflows with efficient, automated communication between sponsors and sites — simplifying trial management and accelerating patient enrollment.
“Joining the Ryght Research Network reflects our commitment to advancing cancer research through thoughtful adoption of cutting-edge AI,” said Madhusmita Behera, PhD, Chief Research Informatics Officer at Winship. “We aim to ensure patients have access to trials that best meet their needs.”
With over 400 active trials, Winship is poised to grow its research portfolio while ensuring timely enrollment and greater operational efficiency.
“Innovation in clinical trial operations is central to our mission at Ryght,” said Chadi Nabhan, MD, Chief Medical Officer at Ryght. “We share Winship’s vision of improving outcomes for cancer patients worldwide.”
Click here to read the original news story.